• Science & Technology

New test predicts how cancers will respond to chemotherapy

A new DNA test could one day help doctors find which chemotherapy drugs are most likely to work for their patients. A new DNA test could one day help doctors find which chemotherapy drugs are most likely to work for their patients.

7 August 2025

• Science & Technology

How the gut microbiome is transforming skin cancer treatment

By studying how the bacteria in our guts can affect the immune system, our researchers have found a potential way to treat melanoma with 'drugs made from bugs'. By studying how the bacteria in our guts can affect the immune system, our researchers have found a potential way to treat melanoma with 'drugs made from bugs'.

22 July 2025

• Health & Medicine

£450,000 given to make cervical screening more comfortable

We've awarded £457,000 to support a study in Cambridge that could be a more comfortable method of collecting potentially harmful cells from the cervix. We've awarded £457,000 to support a study in Cambridge that could be a more comfortable method of collecting potentially harmful cells from the cervix.

21 July 2025

• Science & Technology
• Health & Medicine

Partnering olaparib with chemotherapy helps treat BRCA breast cancers

Our Partner trial has found a new treatment combination for women with inherited breast cancers, with all 39 patients who received it surviving the critical three years after surgery Our Partner trial has found a new treatment combination for women with inherited breast cancers, with all 39 patients who received it surviving the critical three years after surgery

13 May 2025

• Science & Technology

The mysterious stem cells that could hold the key to beating bowel cancer

Researchers at UCL Cancer Institute are closing in on answers to one of bowel cancers' biggest challenges – why people’s cancers respond to treatment differently Researchers at UCL Cancer Institute are closing in on answers to one of bowel cancers' biggest challenges – why people’s cancers respond to treatment differently

9 May 2025

• Policy & Insight

Visiting the Bowelbabe Lab: Why tackling cancer must remain a government priority

Today, Michelle Mitchell, our chief executive, met Wes Streeting at the Bowelbabe Lab in the Crick Institute to discuss why cancer must remain a government priority Today, Michelle Mitchell, our chief executive, met Wes Streeting at the Bowelbabe Lab in the Crick Institute to discuss why cancer must remain a government priority

23 April 2025

• Policy & Insight

Less red tape and lower costs: How the UK-EU political reset can support cancer research progress worldwide

As we launch our new report, “Nothing should stand in the way”, we reflect on how the UK and EU could be more ambitious, grasping opportunities for closer scientific cooperation to promote health and wealth across the continent and beyond As we launch our new report, “Nothing should stand in the way”, we reflect on how the UK and EU could be more ambitious, grasping opportunities for closer scientific cooperation to promote health and wealth across the continent and beyond

22 April 2025

• Health & Medicine

Detecting prostate cancer: why we need more research

We set out why we believe there are currently no easy solutions to prostate cancer early diagnosis, and what we’re doing at Cancer Research UK to change that. We set out why we believe there are currently no easy solutions to prostate cancer early diagnosis, and what we’re doing at Cancer Research UK to change that.

14 April 2025

• Science & Technology

£5.5m research funding to transform bowel cancer care

Along with our partners, we've committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer. Along with our partners, we've committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer.

31 March 2025

• Health & Medicine

Manchester scientists discover simple blood test to spot skin cancer returning

Our DETECTION-2 trial will test a blood test developed by our researchers in Manchester to see if it can help spot signs that melanoma may return Our DETECTION-2 trial will test a blood test developed by our researchers in Manchester to see if it can help spot signs that melanoma may return

20 March 2025